Doctor Shigemasa Tani

Nihon University Hospital, Tokyo (Japan)

Follow

Contributor content

The ratio of eicosapentaenoic acid (EPA) to arachidonic acid may be a residual risk marker in stable coronary artery disease patients receiving treatment with statin following EPA therapy

Presentation

The ratio of eicosapentaenoic acid (EPA) to arachidonic acid may be a residual risk marker in stable coronary artery disease patients receiving treatment with statin following EPA therapy

ESC 365 is supported by

novartis

Explore sponsored resources